Cargando…

LncRNA DLX6-AS1 Contributes to Epithelial–Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis

Triple-negative breast cancer (TNBC) is one of the most aggressive cancer types with high recurrence, metastasis, and drug resistance. Recent studies report that long noncoding RNAs (lncRNAs)-mediated competing endogenous RNAs (ceRNA) play an important role in tumorigenesis and drug resistance of TN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Chuang, Wang, Yan, Zhang, Yingying, Zhang, Jianhua, Zhang, Linfeng, Li, Jingruo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563824/ https://www.ncbi.nlm.nih.gov/pubmed/32686982 http://dx.doi.org/10.1177/0963689720929983

Ejemplares similares

lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis
por: Zhang, Jianhua, et al.
Publicado: (2021)

Hsa_circRNA_102229 facilitates the progression of triple‐negative breast cancer via regulating the miR‐152‐3p/PFTK1 pathway
por: Du, Chuang, et al.
Publicado: (2021)

Strategies of LncRNA DLX6-AS1 on Study and Therapeutics
por: Zhao, Yanyan, et al.
Publicado: (2022)

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
por: Liao, Keman, et al.
Publicado: (2019)

LncRNA DLX6‐AS1 increases the expression of HIF‐1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR‐199a‐5p
por: Yang, Bin, et al.
Publicado: (2019)

Upregulated Circular RNA circ-UBE2D2 Predicts Poor Prognosis and Promotes Breast Cancer Progression by Sponging miR-1236 and miR-1287()
por: Wang, Yan, et al.
Publicado: (2019)

Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer
por: Ding, Xian-zhen, et al.
Publicado: (2021)

DLX2 promotes osteosarcoma epithelial-mesenchymal transition and doxorubicin resistance by enhancing HOXC8-CDH2 axis
por: Zhang, Boya, et al.
Publicado: (2023)

Posterior axis formation requires Dlx5/Dlx6 expression at the neural plate border
por: Narboux-Neme, Nicolas, et al.
Publicado: (2019)

lncRNA DLX6-AS1 Promotes Myocardial Ischemia-Reperfusion Injury through Mediating the miR-204-5p/FBXW7 Axis
por: Wang, Fanshun, et al.
Publicado: (2023)

lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway
por: Liu, Yan, et al.
Publicado: (2020)

The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway
por: Guo, Jinan, et al.
Publicado: (2019)

LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p
por: Hu, Yanping, et al.
Publicado: (2020)

LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis
por: Xin, Yanchao, et al.
Publicado: (2020)

LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis
por: Sun, Wen, et al.
Publicado: (2019)

LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p
por: Kong, Lijun, et al.
Publicado: (2020)

The lncRNA HOTAIR impacts on mesenchymal stem cells via triple helix formation
por: Kalwa, Marie, et al.
Publicado: (2016)

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis
por: Tian, Shubo, et al.
Publicado: (2020)

LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation
por: Zhao, Zhifeng, et al.
Publicado: (2020)

LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1
por: Kuo, Feng-Chih, et al.
Publicado: (2022)

Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
por: Lee, Su Yeon, et al.
Publicado: (2016)

Identification of miR-199-5p and miR-199-3p Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma
por: Tanaka, Nozomi, et al.
Publicado: (2021)

LncRNA SNHG12 promotes the malignant progression of melanoma by targeting miR-199b
por: Xie, Yijie, et al.
Publicado: (2022)

Retraction: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation
Publicado: (2021)

Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer
por: Hu, Xue, et al.
Publicado: (2022)

Paxillin knockdown suppresses metastasis and epithelial-mesenchymal transition in colorectal cancer via the ERK signalling pathway
por: Wen, Long, et al.
Publicado: (2020)

The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death
por: Gupta, Shantanu, et al.
Publicado: (2023)

LncRNA HOTAIR/miR‐613/c‐met axis modulated epithelial‐mesenchymal transition of retinoblastoma cells
por: Yang, Ge, et al.
Publicado: (2018)

LncRNA SNHG12 ameliorates brain microvascular endothelial cell injury by targeting miR-199a
por: Long, Fa-Qing, et al.
Publicado: (2018)

LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer
por: An, Yong, et al.
Publicado: (2018)

Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
por: Wu, Dong-Mei, et al.
Publicado: (2019)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020)

LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis
por: Wang, Yirong, et al.
Publicado: (2019)

Dual impacts of lncRNA XIST and lncRNA SNHG5 on inflammatory reaction and apoptosis of endothelial cells via regulating miR‐155/CARHSP1 axis
por: Song, Xianjing, et al.
Publicado: (2020)

LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
por: Miao, Jin-Tian, et al.
Publicado: (2019)

LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis
por: Du, Ying, et al.
Publicado: (2022)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL)
por: West, Kip A., et al.
Publicado: (2001)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis
por: Zhang, Mingyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8epcgvm8qadu07dejhujqk14eq